AIPCTShop: Pharmaceuticals, Medication & Supplements Guide
  • About AIPCTShop
  • AIPCTShop Terms of Service Agreement
  • Privacy Policy
  • GDPR Compliance Guide
  • Get in Touch
AIPCTShop: Pharmaceuticals, Medication & Supplements Guide
  • About AIPCTShop
  • AIPCTShop Terms of Service Agreement
  • Privacy Policy
  • GDPR Compliance Guide
  • Get in Touch

Category: Health and Policy

GlaxoSmithKline Withdraws Inhaler Patents Amid FTC Crackdown on Non-Inventive Listings
22.03.2024

GlaxoSmithKline Withdraws Inhaler Patents Amid FTC Crackdown on Non-Inventive Listings

In an unprecedented move, GlaxoSmithKline has retracted patent listings for Advair, Flovent, and Ventolin from the FDA’s Orange Book. This decision came after the FTC's scrutiny over non-inventive patent listings intensified, affecting several pharmaceutical companies aiming to maintain market exclusivity.
Arlen Fairweather
by Arlen Fairweather
  • Health and Policy
  • 0

Categories

  • Health and Wellness (29)
  • Health and Medicine (9)
  • Medications (9)
  • Skincare (4)
  • Pharmacy and Medications (4)
  • Legal (3)
  • Health and Fitness (2)
  • Business (2)
  • Health (2)
  • Health and Policy (1)

Latest posts

Exploring Top GoodRx Alternatives for Prescription Savings in 2024
Verapamil's Role in Modern Geriatric Healthcare: Essential Insights
8 Effective Alternatives to Prelone for Managing Inflammation and Autoimmune Diseases
The Role of Exercise in Melanoma Prevention and Recovery
Transform Your Wellness Journey with the Amazing Poisonous Buttercup Supplement

Archives

  • June 2025 (3)
  • May 2025 (3)
  • April 2025 (4)
  • March 2025 (4)
  • February 2025 (3)
  • January 2025 (4)
  • December 2024 (2)
  • October 2024 (2)
  • September 2024 (1)
  • August 2024 (1)
  • July 2024 (1)
  • May 2024 (1)
AIPCTShop: Pharmaceuticals, Medication & Supplements Guide
© 2025. All rights reserved.